Crandall Ryan 4

What Happened
Ryan Crandall, Chief Commercial Officer of Marimed Inc. (MRMD), had 250,000 restricted stock units (RSUs) convert into common shares on June 15, 2026. The conversion is reported as an exercise/conversion of a derivative (code M) at $0.00 exercise price. The company withheld 86,626 shares to satisfy tax withholding obligations (code F) at $0.07 per share, reported as $5,977, leaving Crandall with a net 163,374 shares from this vesting event. This was not an open-market purchase or a sale — it reflects RSU vesting and routine tax withholding.

Key Details

• Transaction date(s): June 15, 2026; Form filed June 16, 2026 (appears timely).
• Conversion/exercise: 250,000 RSUs → 250,000 shares (exercise price reported $0.00).
• Withholding: 86,626 shares withheld at $0.07 per share for taxes, totaling $5,977 (disposed, code F).
• Net shares received: 163,374 (250,000 − 86,626).
• Shares owned after transaction: not specified in the provided excerpt of the filing.
• Footnotes: F1 notes RSUs convert one-for-one to common stock; F2 confirms shares withheld satisfy tax withholding; F3 states the RSU grant was on Dec 15, 2025 and remaining RSUs vest in three installments (Dec 15, 2026; Jun 15, 2027; Dec 15, 2027).
• Transaction codes explained: M = exercise/conversion of derivative (here, RSU conversion), F = shares withheld for taxes.

Context
This was a routine RSU vesting and tax-withholding transaction, not a market buy or sale. Withholding of shares to cover taxes is common and does not by itself indicate insider buying or selling intent. Remaining RSUs from the December 2025 grant will vest on the dates noted in footnote F3.